Reslizumab
RES-2020-20
Approved mab completed
Quick answer
Reslizumab for Asthma; Eosinophilic is a Approved program (mab) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Teva Pharma GmbH
- Indication
- Asthma; Eosinophilic
- Phase
- Approved
- Modality
- mab
- Status
- completed